SCM-AGH

BIOLOGICAL2 trials

Sponsors

SCM Lifescience Co., LTD.

Conditions

Dermatitis, AtopicPancreatitis, Acute

Phase 1

Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis

CompletedNCT04179760

SCM Lifescience Co., LTD.Dermatitis, Atopic

Start: 2020-03-24End: 2022-10-26Updated: 2023-06-08

Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis

CompletedNCT04189419

SCM Lifescience Co., LTD.Pancreatitis, Acute

Start: 2019-08-12End: 2022-03-15Updated: 2023-06-08